325 related articles for article (PubMed ID: 15816365)
1. Prevalence of osteopenia in men with prolactinoma.
Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and magnitude of osteopenia in patients with prolactinoma.
Kayath MJ; Lengyel AM; Vieira JG
Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
[TBL] [Abstract][Full Text] [Related]
3. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
4. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
6. Vertebral fractures in males with prolactinoma.
Mazziotti G; Porcelli T; Mormando M; De Menis E; Bianchi A; Mejia C; Mancini T; De Marinis L; Giustina A
Endocrine; 2011 Jun; 39(3):288-93. PubMed ID: 21479837
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the association between stroke and bone mineral density in elderly Koreans: The Korean National Health and Nutrition Examination Survey, 2008-2010.
Lee JE; Jeon HR; Park JK; Han KD; Kim JH; Yoon J; Park SW; Kim YH; Cho KH
Maturitas; 2017 Jan; 95():1-5. PubMed ID: 27889047
[TBL] [Abstract][Full Text] [Related]
8. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
10. The risk of osteopenia in premenopausal women with various sellar tumors.
Zhao Y; Gan X; Luo P; He Q; Guo Q; Zhang L; Zhang X; Zhang X; Fei Z
Gynecol Endocrinol; 2012 Dec; 28(12):945-8. PubMed ID: 22553947
[TBL] [Abstract][Full Text] [Related]
11. [Decreased bone mineral density in pre-menopause women with prolactinoma].
Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
[TBL] [Abstract][Full Text] [Related]
12. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
14. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
Bruder JM; Ma JZ; Basler JW; Welch MD
Urology; 2006 Jan; 67(1):152-5. PubMed ID: 16413352
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
17. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease is associated with low BMD at the hip but not at the spine.
Bezerra de Carvalho KS; Vasco RFV; Custodio MR; Jorgetti V; Moysés RMA; Elias RM
Osteoporos Int; 2019 May; 30(5):1015-1023. PubMed ID: 30693381
[TBL] [Abstract][Full Text] [Related]
20. Risk of bone loss in men with multiple sclerosis.
Weinstock-Guttman B; Gallagher E; Baier M; Green L; Feichter J; Patrick K; Miller C; Wrest K; Ramanathan M
Mult Scler; 2004 Apr; 10(2):170-5. PubMed ID: 15124763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
